Le Lézard
Classified in: Health
Subjects: MAV, VET, FVT

/R E P E A T -- Media Advisory - Announcement - Minister of Veterans Affairs, Seamus O'Regan, will make an important announcement regarding Veterans' mental health/


OTTAWA, May 3, 2018 /CNW/ - The Honourable Seamus O'Regan, Minister of Veterans Affairs and Associate Minister of National Defence, will help kick off the Canadian Mental Health Association's mental health week with an important announcement from Veterans Affairs Canada. The announcement will be followed by a dynamic panel discussion moderated by Minister O'Regan and will feature mental health professionals from Veterans Affairs Canada, the Canadian Armed Forces and The Royal.

Minister O'Regan, as well as other event participants, will be available to media and for a photo opportunity following the announcement.

This event will also be aired live on Facebook on Veterans Affairs Canada's official page.

Please note that this advisory is subject to change without notice.

 

Location:

Royal Ottawa Mental Health Centre

Winter Garden (2nd floor)

1145 Carling Ave

Ottawa, ON

Date: 

Monday, May 7, 2018

Time:

10:00 a.m. EDT

 

SOURCE Veterans Affairs Canada


These press releases may also interest you

at 07:13
USANA Executive Chairman Kevin Guest Encourages Connections with July's "Social Wellness Month"
Throughout July, Kevin Guest, executive chairman at USANA Health Sciences , is emphasizing boosting social connections during "Social Wellness Month." Social wellness?the ability to form meaningful relationships and interact positively with...

at 07:10
BCEN Welcomes New Marketing and Communications Lead Maris Panjada
The Board of Certification for Emergency Nursing (BCEN), the benchmark for nursing specialty certification across the emergency spectrum, named Maris Panjada as BCEN's new marketing and communications director following the June 28 retirement of...

at 07:05
U.S. Food and Drug Administration (FDA) Approves FoundationOne®Liquid CDx as a Companion Diagnostic for AKEEGA® (niraparib and abiraterone acetate) for Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer
Foundation Medicine, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®Liquid CDx to be used as a companion diagnostic for AKEEGA® (niraparib and abiraterone acetate) from Janssen...

at 07:05
Novocure to Report Second Quarter 2024 Financial Results
Novocure announced today that it will report financial results for the second quarter 2024 on Thursday, July 25, 2024, before the U.S. financial markets open. Novocure management will host a conference call and webcast to discuss the company's...

at 07:05
ASPIRE-FTD Phase 1/2 Clinical Trial Opens in the U.S. at The Ohio State University Wexner Medical Center
AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open and recruiting patients...

at 07:05
Precision BioSciences Announces its Addition to the Russell Microcap® Index
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today...

More news about Health...


News published on and distributed by: